Work

Overall survival and treatment-related outcomes with FOLFIRINOX compared with gemcitabine/nab-paclitaxel in metastatic pancreatic cancer.

Year: 2026

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e16436

Authors: Zaid Zahid, Bugra Zengin, Jamil Nazzal, Mohammad Salameh, Canan Dilay Dirican, Jasneet Randhawa, Abdulla Massad, Salih Akgun, Ahmad Alkhatib, Sanjay Raj Jain

Institutions: Hamilton Medical Center, New York Medical College, St. Mary's Hospital, The University of Texas Medical Branch at Galveston, Hackensack Meridian Health, John F. Kennedy Medical Center, Medical University of South Carolina

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162694471

Cites:

Cited by:

Related to: